Welcome
Support Centre
13 October 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Breathing and relaxation exercises for adult patients diagnosed with asthma in primary care: a randomised controlled trial
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN47120289
Date ISRCTN assigned06/12/2006
Local reference number(s)N/A
Public titleBreathing and relaxation exercises for adult patients diagnosed with asthma in primary care: a randomised controlled trial
Scientific title
AcronymN/A
Disease/condition/study domainAsthma
Study hypothesisAsthma is of global concern and prevalence, thus morbidity and expenditure are increasing. Orthodox medical treatment focuses primarily on pharmaceutical control and education concerning its administration; patients are reported as seeking complementary and alternative therapies wishing to self-manage their condition. The majority of patients are being managed in primary care settings.

Chartered physiotherapists, since the 1960s, have been referred patients with asthma and breathing dysfunction for treatment with the Papworth Method (PM). Patients report improved quality of life but there is little evidence, including from Cochrane reviews, to support the use of breathing and relaxation therapies.

Therefore hypotheses for this trial are that:
1. A specific physical therapy intervention, comprising integrated breathing and relaxation exercises, the Papworth Method (PM), will improve the quality of life for adult asthma patients, already receiving usual medical care, in a primary care population.
2. Anxiety and depression will reduce in this population of patients diagnosed with asthma when treated with the PM.
3. Symptoms from dysfunctional breathing will reduce in this population after treatment with the PM.
4. Respiratory measures will improve (although this study is powered for quality of life and not respiratory function outcomes).
Design/methodologyRandomised controlled trial with an intervention and control arm. Twelve month follow-up. Open label - as this is a therapy trial.
Research ethics reviewHertfordshire Local Research Ethics Committee. Approval granted September 2004 (reference number: EC03660).
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Men and women between 16 and 70 years of age
2. 'Doctor' diagnosed asthma volunteers, recruited from the asthma database of one primary care practice
3. Able to understand, read and write English
4. Willing to give written informed consent
5. Willing and able to attend the local surgery for required number of attendances
Participants - exclusion criteriaSerious co-morbid conditions such as hemiplegia (we aimed to recruit patients typical of the caseload of any semi-rural population of primary care asthma patients in order that this study should be generalisable to similar practices. For the same reason we did not require confirmation of a diagnosis of asthma by reversibility etc.,)
Patient information material
Anticipated start date01/10/2004
Anticipated end date01/02/2006
Status of trialCompleted
Target number of participants56
InterventionsIntegrated breathing and relaxation exercises known as the Papworth Method (PM). These techniques originated and were developed by physiotherapists in the Respiratory Medicine Department of Papworth Hospital, Cambridgeshire, UK in the 1960s.

The five, 60 minute treatments were undertaken by a respiratory physiotherapist in the intervention group between the baseline and six month assessments.

Patients in the control and intervention groups received usual asthma care. The comparisons were between normal care only (the control group) and the intervention group receiving five PM treatments at six months (or post-treatment) and at 12 months post baseline.
Primary outcome measure(s)1. Health related quality of life, as measured by the validated St George¿s Respiratory Questionnaire with three domains (symptoms, activities and impacts) and a total overall score.
Secondary outcome measure(s)1. Anxiety and Depression as measured by the validated Hospital Anxiety and Depression Scale.
2. Symptoms from dysfunctional breathing as measured by the validated Nijmegen Questionnaire.
3. Respiratory measures as measured by spirometry and capnography.
PublicationsResults in:
1. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17573445&dopt=Abstract
Sources of fundingThis study was undertaken as part fulfillment of a PhD at University College London and as such was supported by University College London (UK)
Sponsor nameUniversity College London (UK)
Sponsor detailsDepartment of Epidemiology and Public Health
London
United Kingdom
WC1E 6BT
Sponsor websitehttp://www.ucl.ac.uk/
Contact nameMrs Elizabeth A Holloway
Contact detailsUniversity College London
Department of Epidemiology and Public Health
Gower Street Campus
1-19 Torrington Place
London
United Kingdom
WC1E 6BT
Contact telephone+44 (0)14 3823 5693
Contact fax+44 (0)20 7813 0242
Contact emailannrobson@ntlworld.com
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN47120289
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central